Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Genética | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
INTERVENTIONAL
Inicio: 13 de dic de 2023
ID: NCT06128629
Activo, no recluta
ClinicalTrials.gov
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
OBSERVATIONAL
Inicio: 5 de abr de 2019
ID: NCT03849716
Completado
ClinicalTrials.gov
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
OBSERVATIONAL
Inicio: 22 de abr de 2019
ID: NCT03871816
Activo, no recluta
ClinicalTrials.gov
A Multicenter, Prospective, Non-selection Study for Endometrial Receptivity Analysis Test in Patients With Previous Implantation Failures
OBSERVATIONAL
Inicio: 16 de ene de 2024
ID: NCT06097559
Completado
ClinicalTrials.gov
Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project
OBSERVATIONAL
Inicio: 1 de sept de 2006
ID: NCT01142674
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination With Pembrolizumab Versus Chemotherapy in Subjects With Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma That Expresses HER2 (IHC 1+ and Greater)
INTERVENTIONAL
Inicio: 22 de sept de 2023
ID: NCT05911295
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-onset GM2 Gangliosidosis (Tay-Sachs Disease and Sandhoff Disease) Together With a Separate Basket for Juvenile/Adolescent Late-onset GM2 Gangliosidosis and Ultra-rare Diseases Within the Same and Similar Glucosylceramide-based Sphingolipid Pathway
INTERVENTIONAL
Inicio: 29 de jun de 2020
ID: NCT04221451
Completado
ClinicalTrials.gov
Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease
OBSERVATIONAL
Inicio: 22 de nov de 2017
ID: NCT03233841
Anterior
1
...
4
5
6
...
434
Siguiente
Filtros